Researchers at Karolinska Institutet in Sweden have managed to sequence the giant genome of a salamander, the Iberian ribbed newt, which is a full six times greater than the human genome.
Amongst the early findings is a family of genes that can provide clues to the unique ability of salamanders to rebuild complex tissue, even body parts. The study is published in Nature Communications.
This is the first time that an entire newt genome has been sequenced, an achievement that can give rise to new discoveries on the amphibian’s ability to recreate brain neurons as well as entire body parts. Amongst the first findings are a multitude of copies of a certain microRNA group, which in mammals is mainly found in embryonic stem cells, but also in tumour cells.
“It will be exciting to figure out how regeneration in the adult organism re-activates embryonic genes,” says study leader Professor András Simon at Karolinska Institutet’s Department of Cell and Molecular Biology. “What’s needed now are functional studies of these microRNA molecules to understand their function in regeneration. The link to cancer cells is also very interesting, especially bearing in mind newts’ marked resistance to tumour formation.”
Even though the abundance of stem cell microRNA genes is quite surprising, it alone cannot explain how salamanders regenerate so well. Professor Simon predicts that the explanation lies in a combination of genes unique to salamanders and how other more common genes orchestrate and control the actual regeneration process.
One of the reasons why salamander genomes have not been sequenced before is its sheer size – six times bigger than the human genome in the case of the Iberian newt, which has posed an enormous technical and methodological challenge.
“It’s only now that the technology is available to handle such a large genome,” says Professor Simon. “The sequencing per se doesn’t take that long – it’s recreating the genome from the sequences that’s so time consuming.”
“We all realised how challenging it was going to be,” recounts first author Ahmed Elewa, postdoctoral fellow at the same department. “But the very fact that it was such a challenge made it all the more exciting.”
The group at Karolinska Institutet is now engaging with other researchers to discover what can be learned from the newt genome and test new hypotheses through systematic comparisons with mammals.
“We showed ten years ago that salamanders can recreate all the cells that die in Parkinson’s disease in the space of four weeks,” says Professor Simon. “We can now delve deeply into the molecular processes underlying this ability. Although we’re doing basic research, our findings can hopefully lead to the development of new regenerative strategies for humans.”
Learn more: Salamander genome gives clues about unique regenerative ability
The Latest on: Regenerative medicine
[google_news title=”” keyword=”regenerative medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- TETROUS ANNOUNCES FIRST SURGICAL PROCEDURES USING ENFIX TAC™ DEMINERALIZED BONE FIBER IMPLANTS TO ENHANCE ENTHESIS HEALING IN ROTATOR CUFF REPAIRon May 8, 2024 at 4:31 am
The EnFix product line is specifically designed to address Enthesis Failure Syndrome. The EnFix technology utilizes proprietary demineralized cortical bone fibers to yield an oste ...
- Regenerative medicine could help patients find relief from chronic nerve and joint painon May 7, 2024 at 7:53 pm
If you've struggled with issues like joint pain, osteoarthritis or neuropathy, you may have been told the only way to find relief is through drugs or surgery -- or that nothing at all will help. The ...
- Global Regenerative Medicine Industry Analysis Reveals Significant Collaboration and Licensing Trends from 2016 to 2024on May 7, 2024 at 4:03 am
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. A comprehensive analysis of regenerative medicine collaboration and ...
- BioStem Technologies Granted Prioritized Examination for Wound Healing Patenton May 6, 2024 at 7:00 am
Once granted, the patent will protect BioStem’s method of processing human amniotic tissue. The global wound care dressing market was valued at $14.20 billion in 2023 and is projected to grow at a ...
- Regenerative Medicine and the Developing Worldon May 4, 2024 at 5:00 pm
[1] As the field of regenerative medicine regroups, it is important that recent events do not overshadow the potential benefits of the field. These benefits include the opportunity to improve ...
- New institute to leverage experts to advance regenerative medicineon May 3, 2024 at 4:30 am
The lnstitute of Regenerative Medicine will provide a unique resource and collection of research and expertise for UTSA and San Antonio communities. “We really want the institute to very much be ...
- Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)on April 30, 2024 at 1:00 am
CIRM’s mission is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world as well as to accelerate stem ...
- Cabinet approves two bills on regenerative medicineon April 25, 2024 at 9:00 am
The draft regenerative medicine bill stipulates that only government-certified medical institutions can administer such treatments, with individuals or organizations that administer them without ...
- What Is Drug Repurposing And Why Is It A Game-Changer In Regenerative Medicine?on April 23, 2024 at 7:55 am
Repurposed drugs have already undergone rigorous testing for safety and efficacy in other medical conditions. It enables researchers to fast-track their investigations, saving time and resources.
- Immunotherapy Regenerative Medicine Clinic on Using Stem Cells to Activate the Body's Natural Healing Poweron April 18, 2024 at 4:01 am
Stem cell therapy, a cornerstone of regenerative medicine, has shown immense potential in treating autoimmune diseases, aging conditions, and neurological and musculoskeletal disorders.
via Google News and Bing News